Rui Martins, Bruno de Sousa & Vítor Rodrigues. (2022) The geography of the age at menopause in central Portugal since the early twentieth century. Scientific Reports 12:1.
Crossref
Niki Sadat Afjeh, Priyanka Lamba & Alefiya Eski. (2021) Potential Impact of Exercise-Associated Amenorrhea and Subsequent Estrogen Therapy on Cardiovascular Disease Risk Factors in Pre-Menopausal Athletes: A Research Protocol. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 5:4, pages 1-13.
Crossref
Annabelle Brennan & Martha Hickey. (2021) Management of Early Menopause/Premature Ovarian Insufficiency in Women with or at High Risk of Breast Cancer. Seminars in Reproductive Medicine 38:04/05, pages 309-314.
Crossref
Theresa Burkard, Manon Moser, Marlene Rauch, Susan S. JickChristoph R. Meier. (2019) Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive study. Menopause 26:7, pages 741-749.
Crossref
Ai-jun Sun, Ya-ping Wang, Bei Gu, Ting-ping Zheng, Shou-qing Lin, Wen-pei Bai, Yang Wei, Shao-fen Zhang & Ying Zhang. (2016) A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women. Chinese Journal of Integrative Medicine 24:7, pages 487-493.
Crossref
Manuela Cristina Russu & Alexandra Cristina Antonescu. 2018. Sex Hormones in Neurodegenerative Processes and Diseases. Sex Hormones in Neurodegenerative Processes and Diseases.
Ji Hee Jun, Hye Won Lee, Junhua Zhang, Fengwen Yang & Myeong Soo Lee. (2018) Herbal medicine (Danggui Liuhuang decoction) for managing menopausal symptoms. Medicine 97:4, pages e9735.
Crossref
Louiza S. Velentzis, Usha Salagame & Karen Canfell. (2017) Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations. BMC Health Services Research 17:1.
Crossref
Meena Dayal & Preeti Yadav. (2017) Management of Postmenopausal Vaginal Atrophy: Review of Literature. Journal of SAFOMS 5:1, pages 51-57.
Crossref
Ki-Jin Ryu, Hyun-Tae Park, Yong Jin Kim, Kyong Wook Yi, Jung Ho Shin, Jun Young Hur & Tak Kim. (2016) Vasomotor symptoms and osteoporosis in Korean postmenopausal women. Maturitas 87, pages 27-32.
Crossref
Stephanie L. Sherman, Emily G. Allen, Jessica B. Spencer & Lawrence M. Nelson. 2016. FXTAS, FXPOI, and Other Premutation Disorders. FXTAS, FXPOI, and Other Premutation Disorders
199
224
.
Supriya Bulchandani, Philip Toozs-Hobson, Tina Verghese & Pallavi Latthe. (2015) Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?. Post Reproductive Health 21:4, pages 141-145.
Crossref
D. Tierney, Oxana Palesh & Laura Johnston. (2015) Sexuality, Menopausal Symptoms, and Quality of Life in Premenopausal Women in the First Year Following Hematopoietic Cell Transplantation. Oncology Nursing Forum 42:5, pages 488-497.
Crossref
J. Sassarini & M. A. Lumsden. (2015) Oestrogen replacement in postmenopausal women. Age and Ageing 44:4, pages 551-558.
Crossref
Sarah E. McBane, Laura M. Borgelt, Kylie N. Barnes, Sarah M. Westberg, Nicole M. Lodise & Martha Stassinos. (2014) Use of Compounded Bioidentical Hormone Therapy in Menopausal Women: An Opinion Statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:4, pages 410-423.
Crossref
Gloria Richard-Davis. (2014) Are acupuncture and Chinese herbal medicine effective options for hot flashes?. Menopause 21:1, pages 3-5.
Crossref
Mar?a F. Perell?Anna Peguero, Cristina Ros, Mar?a Jos? Mart?nez-Serrano & Camil Castelo-Branco. (2013) Fracturas vertebrales tras tratamiento hormonal en la menopausia: 20 a?os de seguimiento. Progresos de Obstetricia y Ginecolog?a 56:9, pages 462-466.
Crossref
Dana Brown, Amy Henneman & Darshana Desai. (2013) Efficacy of Drospirenone-Containing Hormone Replacement Therapy to Reduce Vasomotor Symptoms of Menopause. Pharmacy 1:2, pages 193-203.
Crossref
H.-J. Ahrendt & C. Friedrich. 2013. Die Gynäkologie. Die Gynäkologie
1069
1082
.
Tarja Saaresranta, Päivi Polo-Kantola & Olli Polo. 2013. Sleep Disorders in Women. Sleep Disorders in Women
293
324
.
Saima Rafique, Evelina W. Sterling & Lawrence M. Nelson. (2012) A New Approach to Primary Ovarian Insufficiency. Obstetrics and Gynecology Clinics of North America 39:4, pages 567-586.
Crossref
Nick Panay. 2012. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
553
564
.
Jasmina-Ziva Cerne, Snjezana Frkovic-Grazio & Ksenija Gersak. (2011) Breast Tumor Characteristics in Hormone Replacement Therapy Users. Pathology & Oncology Research 17:4, pages 917-923.
Crossref
María‐del‐Carmen Cravioto, Marta Durand‐Carbajal, Luisa Jiménez‐Santana, Pilar Lara‐Reyes, Armando H. Seuc & Jorge Sánchez‐Guerrero. (2011) Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: A randomized, double‐blind, controlled trial. Arthritis Care & Research 63:12, pages 1654-1663.
Crossref
MinFang Tao, YinCheng Teng, HongFang Shao, Ping Wu & Edward J. Mills. (2011) Knowledge, Perceptions and Information about Hormone Therapy (HT) among Menopausal Women: A Systematic Review and Meta-Synthesis. PLoS ONE 6:9, pages e24661.
Crossref
V.W. Henderson & R.A. Popat. (2011) Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions. Neuroscience 191, pages 129-138.
Crossref
S. V. Yureneva, V. B. Mychka, L. M. Ilyina & S. N. Tolstov. (2011) Cardiovascular risk factors in women and the role of sex hormones. Cardiovascular Therapy and Prevention 10:4, pages 128-135.
Crossref
Bart C. J. M. Fauser, Joop S. E. Laven, Basil C. Tarlatzis, Kelle H. Moley, Hilary O. D. Critchley, Robert N. Taylor, Sarah L. Berga, Paul G. Mermelstein, Paul Devroey, Luca Gianaroli, Thomas D’Hooghe, Paolo Vercellini, Lone Hummelshoj, Susan Rubin, Angelique J. Goverde, Vincenzo De Leo & Felice Petraglia. (2011) Sex Steroid Hormones and Reproductive Disorders. Reproductive Sciences 18:8, pages 702-712.
Crossref
Sandra A. Tsai, Marcia L. Stefanick & Randall S. Stafford. (2011) Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009. Menopause 18:4, pages 385-392.
Crossref
Sovra Whitcroft & Anne Herriot. (2011) Insulin resistance and management of the menopause: a clinical hypothesis in practice. Menopause International 17:1, pages 24-28.
Crossref
John C. Stevenson, Gemma Durand, Elke Kahler & Tomasz Perty?ski. (2010) Oral ultra-low dose continuous combined hormone replacement therapy with 0.5mg 17?-oestradiol and 2.5mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study. Maturitas 67:3, pages 227-232.
Crossref
James Simon, Lila Nachtigall, Lian G. Ulrich, Michaela Eugster-Hausmann & Robert Gut. (2010) Endometrial Safety of Ultra-Low-Dose Estradiol Vaginal Tablets. Obstetrics & Gynecology 116:4, pages 876-883.
Crossref
Ling Xu. (2010) How to judge the association of postmenopausal hormone therapy and the risk of breast cancer. Frontiers of Medicine in China 4:3, pages 290-293.
Crossref
C. Bergeron, F.F. Nogales, T. Rechberger, T. Tatarchjuk & L. Zipfel. (2010) Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17β-oestradiol and 2.5mg dydrogesterone: Protection of the endometrium and amenorrhoea rate. Maturitas 66:2, pages 201-205.
Crossref
Alexandra Rousseau, Annie Robert, Grigoris Gerotziafas, Dahlia Torchin, Faiez Zannad, Karine Lacut, Christian Libersa, Eric Dasque, Jean‐Louis Démolis, Ismail Elalamy & Tabassome Simon. (2010) Effect of two oral doses of 17β‐estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double‐blind placebo‐controlled study. Fundamental & Clinical Pharmacology 24:2, pages 239-245.
Crossref
Marianne CanonicoAgnès FournierLaure CarcaillonValérie OliéGeneviève Plu-BureauEmmanuel OgerSylvie MesrineMarie-Christine Boutron-RuaultFrançoise Clavel-ChapelonPierre-Yves Scarabin. (2010) Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology 30:2, pages 340-345.
Crossref
Lynne T. Shuster, Deborah J. Rhodes, Bobbie S. Gostout, Brandon R. Grossardt & Walter A. Rocca. (2010) Premature menopause or early menopause: Long-term health consequences. Maturitas 65:2, pages 161-166.
Crossref
M. Birkäuser. (2010) Depression und ÖstrogeneDepression and estrogens. Gynäkologische Endokrinologie 8:1, pages 82-88.
Crossref
Hyoung Moo Park. (2010) Current use of drugs for osteoporosis in Korea. Korean Journal of Obstetrics and Gynecology 53:2, pages 152.
Crossref
Jeong Yuen KimJae Hong SangHyoung Moo Park. (2010) The change of hormone therapy in postmenopausal women in Korea before and after women's health initiative study: 2000~2009. Korean Journal of Obstetrics and Gynecology 53:12, pages 1110.
Crossref
Susan Reinwald, Loretta P. Mayer, Patricia B. Hoyer, Charles H. Turner, Stephen Barnes & Connie M. Weaver. (2010) A Longitudinal Study of the Effect of Genistein on Bone in Two Different Murine Models of Diminished Estrogen-Producing Capacity. Journal of Osteoporosis 2010, pages 1-14.
Crossref
Margaret E. Wierman, Rossella E. Nappi, Nancy Avis, Susan R. Davis, Ferdinand Labrie, Willam Rosner & Jan L. Shifren. (2010) Endocrine Aspects of Women's Sexual Function. The Journal of Sexual Medicine 7:1, pages 561-585.
Crossref
Lotta Lindh-Åstrand, Marie Bixo, Angelica Lindén Hirschberg, Inger Sundström-Poromaa & Mats Hammar. (2010) A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms. Menopause 17:1, pages 72-79.
Crossref
H. Rozenbaum. (2010) Ménopause. EMC - Endocrinologie - Nutrition 7:4, pages 1-19.
Crossref
Amber R. Cooper, Sharon N. Covington & Lawrence M. Nelson. 2010. Amenorrhea. Amenorrhea
55
82
.
Tarja Saaresranta, Päivi Polo-Kantola & Olli Polo. 2010. Clinical Handbook of Insomnia. Clinical Handbook of Insomnia
117
136
.
Augusto Ferrari. (2009) Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetrics and Gynaecology Research 35:6, pages 1083-1090.
Crossref
V. Shenoy, J.L. Grobe, Y. Qi, A.J. Ferreira, R.A. Fraga-Silva, G. Collamat, E. Bruce & M.J. Katovich. (2009) 17?-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 30:12, pages 2309-2315.
Crossref
Alfred O. Mueck, Harald Seeger & Kai-J. Bühling. (2009) Use of dydrogesterone in hormone replacement therapy. Maturitas 65, pages S51-S60.
Crossref
Wolfgang Junge, Volker El-Samalouti, Christoph Gerlinger & Matthias Schaefers. (2009) Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: Open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate. European Journal of Obstetrics & Gynecology and Reproductive Biology 147:2, pages 195-200.
Crossref
John C. Stevenson, Howard N. Hodis, James H. Pickar & Rogerio A. Lobo. (2009) Coronary heart disease and menopause management: The swinging pendulum of HRT. Atherosclerosis 207:2, pages 336-340.
Crossref
Shelley R. Salpeter, Ji Cheng, Lehana Thabane, Nicholas S. Buckley & Edwin E. Salpeter. (2009) Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women. The American Journal of Medicine 122:11, pages 1016-1022.e1.
Crossref
E. Anne MacGregor. (2009) Migraine headache in perimenopausal and menopausal women. Current Pain and Headache Reports 13:5, pages 399-403.
Crossref
Gabriela Barbaglia, Francesc Macià, Mercè Comas, Maria Sala, Maria del Mar Vernet, Montserrat Casamitjana & Xavier Castells. (2009) Trends in hormone therapy use before and after publication of the Women's Health Initiative trial. Menopause 16:5, pages 1061-1064.
Crossref
Alastair H MacLennan. (2009) Evidence-based review of therapies at the menopause. International Journal of Evidence-Based Healthcare 7:2, pages 112-123.
Crossref
Rossella E. Nappi & Franco Polatti. (2009) Continuing Medical Education: The Use of Estrogen Therapy in Women's Sexual Functioning (CME). The Journal of Sexual Medicine 6:3, pages 603-616.
Crossref
Carolina Sales Vieira, Fábio Vasconcelos Pereira, Marcos Felipe Silva de Sá, Paulo Louzada Júnior, Wellington Paula Martins & Rui Alberto Ferriani. (2009) Tibolone in postmenopausal women with systemic lupus erythematosus: A pilot study. Maturitas 62:3, pages 311-316.
Crossref
Chen-Yu Huang, Chong-Yau Fu, Jen-Yu Tseng, Tzay-Shing Yang & Kuan-Chong Chao. (2009) The Effects of Continuous Combined Oral Estradiol and Norethisterone on Pulsatility Index in Internal Carotid and Uterine Arteries in Early Postmenopausal Taiwanese Women—A Preliminary Study. Taiwanese Journal of Obstetrics and Gynecology 48:1, pages 60-64.
Crossref
Lawrence M. Nelson. (2009) Primary Ovarian Insufficiency. New England Journal of Medicine 360:6, pages 606-614.
Crossref
Tobias Johannes de Villiers. (2009) Bone health and osteoporosis in postmenopausal women. Best Practice & Research Clinical Obstetrics & Gynaecology 23:1, pages 73-85.
Crossref
Alastair H. MacLennan. (2009) Hormone replacement therapy: a 2008 perspective. Obstetrics, Gynaecology & Reproductive Medicine 19:1, pages 13-18.
Crossref
E. Anne MacGregor. (2008) Headache and hormone replacement therapy in the postmenopausal woman. Current Treatment Options in Neurology 11:1, pages 10-17.
Crossref
Olaf Ortmann & Peyman Hadji. 2009. Klinische Endokrinologie für Frauenärzte. Klinische Endokrinologie für Frauenärzte
521
559
.
Kathryn B. Horwitz. (2008) Commentary: The Year in Basic Science: Update of Estrogen Plus Progestin Therapy for Menopausal Hormone Replacement Implicating Stem Cells in the Increased Breast Cancer Risk. Molecular Endocrinology 22:12, pages 2743-2750.
Crossref
Débora Vieira Soares, Flávia Lúcia Conceição & Mário Vaisman. (2008) Aspectos diagnósticos e terapêuticos da síndrome de Sheehan. Arquivos Brasileiros de Endocrinologia & Metabologia 52:5, pages 872-878.
Crossref
Odd Erik Johansen & Erik Qvigstad. (2008) Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Advances in Therapy 25:6, pages 525-551.
Crossref
David W. Sturdee. (2008) The menopausal hot flush—Anything new?. Maturitas 60:1, pages 42-49.
Crossref
D. Foth. (2008) Nahrungsergänzungsmittel im KlimakteriumDietary supplements during menopause. Gynäkologische Endokrinologie 6:2, pages 76-81.
Crossref
G. Emons. (2008) Hormontherapie mit Östrogenen und Gestagenen in der Peri- und PostmenopauseHormone therapy with estrogens and gestagens in peri- and post-menopause. Der Internist 49:5, pages 553-558.
Crossref
Jung Gu Kim, Jung Hwa Kim, Dong Ock Lee, Hoon Kim, Ja Yeon Kim, Chang Suk Suh, Seok Hyun Kim & Young Min Choi. (2008) Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor κB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. Menopause 15:2, pages 357-362.
Crossref
Päivi Polo-Kantola. (2008) Dealing with Menopausal Sleep Disturbances. Sleep Medicine Clinics 3:1, pages 121-131.
Crossref
D.W. Sturdee. 2008. International Encyclopedia of Public Health. International Encyclopedia of Public Health
335
343
.
E Anne MacGregor. (2007) Migraine, the menopause and hormone replacement therapy: a clinical review. Journal of Family Planning and Reproductive Health Care 33:4, pages 245-249.
Crossref
I. Wiegratz & H. Kuhl. (2007) Praxis der Hormontherapie in der Peri- und PostmenopausePractice of peri- and postmenopausal hormone therapy. Gynäkologische Endokrinologie 5:3, pages 141-149.
Crossref
A.O. Mueck & H. Seeger. (2007) Kardiovaskuläre Risiken unter HRT in der PostmenopauseCardiovascular risks in postmenopausal women receiving HRT. Gynäkologische Endokrinologie 5:3, pages 120-126.
Crossref
Michael E. Mendelsohn & Richard H. Karas. (2007) HRT and the Young at Heart. New England Journal of Medicine 356:25, pages 2639-2641.
Crossref